Ulcerative Colitis and Vitamin D - many studies

---

12+ Vitamin D pages with "Ulcerative Colitis" or UC in the title

---

Ulcerative Colitis is 1.9 X more likely if low Vitamin D – meta-analysis Oct 2023

The correlation between serum 25-hydroxyvitamin D level and ulcerative colitis: a systematic review and meta-analysis
Eur J Gastroenterol Hepatol . 2023 Oct 18. doi: 10.1097/MEG.0000000000002670 PDF is behind a $47 paywall
Chenyu Liu 1, Xin Liu, Haitao Shi, Fenrong Chen, Linlang Sun, Xin Gao, Yan Wang

Objective: The incidence of UC has increased yearly. Many studies have suggested that patients with ulcerative colitis have abnormal vitamin D levels. A systematic review and meta-analysis were conducted to investigate the association between vitamin D levels and ulcerative colitis.

Methods: We searched PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure, Wanfang and China Science and Technology Journal Database (VIP) from inception to December 2022. We included case-control studies comparing the differences in vitamin D levels between patients with ulcerative colitis and healthy populations. Meta-analysis was performed using Review Manager5.4, Stata17.0 and other software.

Results: Sixteen eligible observational studies were selected from 473 articles involving 2234 subjects, and they included 987 patients with ulcerative colitis and 1247 controls. The results showed that the serum level of vitamin D in patients with ulcerative colitis was significantly lower than that in healthy controls (SMD = -0.83, 95% CI: -1.18, -0.48). Vitamin D deficiency was reported in five studies. The prevalence of vitamin D deficiency was significantly higher in the ulcerative colitis group than in the healthy control group (OR = 1.90, 95% CI: 1.38, 2.62).

Conclusion: Serum vitamin D levels were significantly lower in patients with ulcerative colitis than in healthy controls.

References

• Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. ulcerative colitis. Lancet 2012; 380:1606–1619.
• da Silva BC, Lyra AC, Rocha R, Santana GO. Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis. World J Gastroenterol 2014; 20:9458–9467.
• Vernia F, Valvano M, Longo S, Cesaro N, Viscido A, Latella G. Vitamin D in inflammatory bowel diseases mechanisms of action and therapeutic implications. Nutrients 2022; 14:269.
• Fakhoury HMA, Kvietys PR, AlKattan W, Anouti FA, Elahi MA, Karras SN, et al. Vitamin D and intestinal homeostasis: Barrier, microbiota, and immune modulation. J Steroid Biochem Mol Biol 2020; 200:105663.
• Domazetovic V, Iantomasi T, Bonanomi AG, Stio M. Vitamin D regulates claudin-2 and claudin-4 expression in active ulcerative colitis by p-Stat-6 and Smad-7 signaling. Int J Colorectal Dis 2020; 35:1231–1242.
• Tangestani H, Boroujeni HK, Djafarian K, Emamat H, Shab-Bidar S. Vitamin D and the gut microbiota: a narrative literature review. Clin Nutr Res 2021; 10:181–191.
• Xie C, Chen W, Sun J. Correlation analysis of serum lipid carrier protein-2, 25-hydroxyvitamin D and disease activity in patients with ulcerative colitis (in Chinese). J Med Theory Pract, 2022; 35:2991–2993.
• Jin C. The level of serum vitamin D and interleukin 17 in Patients with ulcerative colitis. Dalian Medical University, 2017.
• Jiajia W, Qiaomin W, Zhengxiang WU, Qiuxia J, Xiuli Z, Ting LI. Impact of serum 25OHD level on disease activity and quality of life in patients with ulcerative colitis. Gastroenterology 2017; 22:25–29.
• Yan L, Ran Z, Lian-jie L, Yu J, Yong C, Chang-qing Z. Association of serum 25 (OH) vitamin D levels with ulcerative colitis activity. Prog anat sci 2014; 20:142–144 + 150.
• Bo Z, Jihua P, Jianzhang W, Shuguang C. An analysis of vitamin D receptor FokI gene polymorphism and vitamin D levels in patients with ulcerative colitis. Chin J Exp Sur 2016; 33:221–224.
• Wang HQ, Zhang WH, Wang YQ, Geng X-P, Wang M-W, Fan Y-Y, et al. Colonic vitamin D receptor expression is inversely associated with disease activity and jumonji domain-containing 3 in active ulcerative colitis. World J Gastroenterol 2020; 26:7352–7366.
• Zheng SZ, Zhang DG, Wu H, Jiang L-J, Jin J, Lin X-Q, et al. The association between vitamin D receptor polymorphisms and serum 25-hydroxyvitamin D levels with ulcerative colitis in Chinese Han population. Clin Res Hepatol Gastroenterol 2017; 41:110–117.
• Krela-Kazmierczak I, Szymczak-Tomczak A, Tomczak M, Lykowska-Szuber L, Eder P, Kucharski MA, et al. Is there a relation between vitamin D, interleukin-17, and bone mineral density in patients with inflammatory bowel disease? Arch Med Sci 2018; 17:662–674.
• Huang J, Chen T, Liu Y, Lyu L, Li X, Yue W. How would serum 25(OH)D level change in patients with inflammatory bowel disease depending on intestinal mucosa vitamin D receptor (VDR) and vitamin D1-α hydroxylase (CYP27B1)? Turk J Gastroenterol 2019; 30:132–138.
• Dumitrescu G, Mihai C, Dranga M, Prelipcean CC. Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania. World J Gastroenterol 2014; 20:2392–2396.
• Veit LE, Maranda L, Fong J, Nwosu BU. The vitamin D status in inflammatory bowel disease. PLoS One 2014; 9:e101583.
• Gilman J, Shanahan F, Cashman KD. Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther 2006; 23:1007–1016.
• Ko KH, Kim YS, Lee BK, Choi JH, Woo YM, Kim JY, et al. Vitamin D deficiency is associated with disease activity in patients with Crohn’s disease. Intest Res 2019; 17:70–77.
• El-Matary W, Sikora S, Spady D. Bone mineral density, vitamin D, and disease activity in children newly diagnosed with inflammatory bowel disease. Dig Dis Sci 2011; 56:825–829.
• Grunbaum A, Holcroft C, Heilpern D, Gladman S, Burstein B, Menard M, et al. Dynamics of vitamin D in patients with mild or inactive inflammatory bowel disease and their families. Nutr J 2013; 12:145.
• Zhao J, Wang Y, Gu Q, Du Z, Chen W. The association between serum vitamin D and inflammatory bowel disease. Medicine (Baltim) 2019; 98:e15233.
• Klapkova E, Cepova J, Pechova M, Dunovska K, Kotaska K, Prusa R. A Comparison of four methods (Immunochemistry and HPLC) for determination of 25-(OH)-vitamin D in postmenopausal women. Clin Lab 2017; 63:385–388.
• Blanck S, Aberra F. Vitamin d deficiency is associated with ulcerative colitis disease activity. Dig Dis Sci 2013; 58:1698–1702.
• Janssen CE, Globig AM, Busse Grawitz A, Bettinger D, Hasselblatt P. Seasonal variability of vitamin D status in patients with inflammatory bowel disease - a retrospective cohort study. PLoS One 2019; 14:e0217238.
• Law AD, Dutta U, Kochhar R, Vaishnavi C, Kumar S, Noor T, et al. Vitamin D deficiency in adult patients with ulcerative colitis: Prevalence and relationship with disease severity, extent, and duration. Indian J Gastroenterol 2019; 38:6–14.
• Dash KR, Panda C, Das HS, Mishra D, Behera SK, Parida PK, et al. Association of vitamin D level with disease severity and quality of life in newly diagnosed patients of ulcerative colitis: a cross-sectional analysis. Cureus 2021; 13:e16481.
• Skaaby T, Husemoen LL, Thuesen BH, Linneberg A. Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease. Endocrine 2015; 50:231–238.
• Opstelten JL, Chan SSM, Hart AR, van Schaik FDM, Siersema PD, Lentjes EGWM, et al. Prediagnostic serum vitamin D levels and the risk of Crohn’s disease and ulcerative colitis in European populations: a nested case-control study. Inflamm Bowel Dis 2018; 24:633–640.
• Ahamed ZR, Dutta U, Sharma V, et al. Oral nano vitamin D supplementation reduces disease activity in ulcerative colitis: a double-blind randomized parallel group placebo-controlled trial. J Clin Gastroenterol 2019; 53:e409–e415.
• Garg M, Hendy P, Ding JN, Shaw S, Hold G, Hart A. The effect of vitamin D on intestinal inflammation and faecal microbiota in patients with ulcerative colitis. J Crohns Colitis 2018; 12:963–972.
• Sharifi A, Hosseinzadeh-Attar MJ, Vahedi H, Nedjat S. A randomized controlled trial on the effect of vitamin D3 on inflammation and cathelicidin gene expression in ulcerative colitis patients. Saudi J Gastroenterol 2016; 22:316–323.
• Sharifi A, Vahedi H, Nedjat S, Mohamadkhani A, Hosseinzadeh Attar MJ. Vitamin D decreases Beck depression inventory score in patients with mild to moderate ulcerative colitis: a double-blind randomized placebo-controlled trial. J Diet Suppl 2019; 16:541–549.
• Karimi S, Tabataba-Vakili S, Yari Z, Alborzi F, Hedayati M, Ebrahimi-Daryani N, et al. The effects of two vitamin D regimens on ulcerative colitis activity index, quality of life and oxidant/anti-oxidant status. Nutr J 2019; 18:16..

---

UC reduced by Selenium - RCT July 2023

The effect of selenium supplementation on disease activity and immune-inflammatory biomarkers in patients with mild-to-moderate ulcerative colitis: a randomized, double-blind, placebo-controlled clinical trial
European Journal of Nutrition (2023)
Maryam Khazdouz, Naser Ebrahimi Daryani, Makan Cheraghpour, Foroogh Alborzi, Motahareh Hasani, Shaghayegh Baradaran Ghavami & Farzad Shidfar

Purpose
Selenium (Se) supplementation may help reduce inflammation and disease activity in ulcerative colitis (UC) patients. We investigated the therapeutic effects of Se administration in cases with mild-to-moderate active UC.

Methods
A multicenter, double-blind, randomized clinical trial (RCT) was conducted on 100 cases with active mild-to-moderate UC. The patients were randomly allocated to be given an oral selenomethionine capsule (200 mcg/day, n = 50) or a placebo capsule (n = 50) for 10 weeks. The primary outcome was defined as disease activity via the Simple Clinical Colitis Activity Index (SCCAI), and secondary outcomes were measured at the end of the study.

Results
After 10 weeks, the SCCAI score's mean was reduced in the Se group (P < 0.001). At the end of the intervention, clinical improvement (decline of 3 ≥ score from baseline score) was observed in 19 patients (38%) of the Se group and 3 patients (6%) of the placebo group. The patients with clinical remission (defined as SCCAI ≤ 2) were assigned in the Se group (P = 0.014). The Se group’s quality of life and Se serum levels were enhanced at the end of the study (P < 0/001). In the Se group, the mean concentration of interleukin-17 decreased (P < 0/001). However, the levels of interleukin-10 showed no considerable change between the two groups in the 10th week (P = 0.23).

Conclusion
Se supplementation as add-on therapy with medical management induced remission and improved the quality of life in patients with active mild-to-moderate UC.
 Download the PDF from VitaminDWiki

This study was reviewed by Examine.com

---

Selenium is important to health - many studies 16+ studies

---

There have been 127187 visits to this page